about
Respiratory Syncytial Virus and Cellular Stress Responses: Impact on Replication and PhysiopathologyDetection of IKKε by immunohistochemistry in primary breast cancer: association with EGFR expression and absence of lymph node metastasis.Genome-wide RNAi screen reveals a new role of a WNT/CTNNB1 signaling pathway as negative regulator of virus-induced innate immune responses.Fludarabine downregulates indoleamine 2,3-dioxygenase in tumors via a proteasome-mediated degradation mechanism.Redox-modulating agents target NOX2-dependent IKKε oncogenic kinase expression and proliferation in human breast cancer cell lines2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV.STAT2 and IRF9: Beyond ISGF3.Lung epithelial NOX/DUOX and respiratory virus infections.A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3.Sustained activation of interferon regulatory factor 3 during infection by paramyxoviruses requires MDA5.IFNβ/TNFα synergism induces a non-canonical STAT2/IRF9-dependent pathway triggering a novel DUOX2 NADPH oxidase-mediated airway antiviral response.HIV-1 selectively targets gut-homing CCR6+CD4+ T cells via mTOR-dependent mechanisms.Pathogen recognition receptor crosstalk in respiratory syncytial virus sensing: a host and cell type perspective.1st Workshop of the Canadian Society for Virology.DUSP1 regulates apoptosis and cell migration, but not the JIP1-protected cytokine response, during Respiratory Syncytial Virus and Sendai Virus infection.Virus Infection Triggers MAVS Polymers of Distinct Molecular Weight.Structural basis of STAT2 recognition by IRF9 reveals molecular insights into ISGF3 function.Interleukin (IL)-6 Inhibits IL-27- and IL-30-Mediated Inflammatory Responses in Human Monocytes.CSV2018: The 2nd Symposium of the Canadian Society for VirologyTherapeutic Targeting of RIG-I and MDA5 Might Not Lead to the Same RomeThe Combination of IFN β and TNF Induces an Antiviral and Immunoregulatory Program via Non-Canonical Pathways Involving STAT2 and IRF9
P50
Q26748983-E6801EC1-80AE-43C2-AB18-C60BAAA5D34AQ33717414-854EB55D-E3AC-45F9-88C1-4C080E332F6AQ34778497-65021373-B0D3-49D0-8D52-67A0B360E1A9Q35184110-98263523-1B7E-459A-A649-297AA76E5526Q35880182-5D6BD58C-39BA-4EE3-B4EF-C9368B31BD1BQ37198046-3EEB7A2C-0EB7-4414-9837-38669606188DQ38185399-96278870-4DBD-4140-8532-995DA841DA26Q38279714-7F4049DA-BE93-4383-A0A4-2624842AA6A9Q38795250-4E8CFBD1-DA82-4DBD-8DC8-70F258B7C258Q38998010-410ACAA1-7B57-4D61-9221-5E8BD3A285F3Q39172917-47733BE3-0CB9-48A7-9A06-D3617A5E7EECQ40097445-7922F0C2-5334-47E1-97E5-411C9A428868Q40721454-DDA7268F-02E6-4820-8558-A8D8383B5C6CQ42370476-BE2E0DC0-A548-48F5-AF85-3D18896C7C5DQ47140901-BDE9408E-9D8D-4D02-8197-3370FF0AC9EAQ47547569-9DE84B75-AA79-4A03-A650-14D27E5B1BA4Q48276990-9286F167-B3B1-41C0-A869-BF28B2FE976BQ55365932-C85925E2-0D18-4C1F-964F-3B682C85F6E2Q61813822-D31F3062-592D-4BF4-9E04-D7A8C117A379Q90868898-60A6B545-893C-412C-B12A-290B513588A8Q92702930-788491F8-C955-4BD3-8A25-A2379B6ABEFB
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Nathalie Grandvaux
@en
Nathalie Grandvaux
@nl
type
label
Nathalie Grandvaux
@en
Nathalie Grandvaux
@nl
prefLabel
Nathalie Grandvaux
@en
Nathalie Grandvaux
@nl
P31
P496
0000-0003-0567-0284